These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2069377

  • 1. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.
    Hayton WL, Walstad RA, Thurmann-Nielsen E, Kufaas T, Kneer J, Ambros RJ, Rugstad HE, Monn E, Bodd E, Stoeckel K.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):720-5. PubMed ID: 2069377
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL, Kneer J, Blouin RA, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.
    Kneer J, Tam YK, Blouin RA, Frey FJ, Keller E, Stathakis C, Luginbuehl B, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers.
    Tam YK, Kneer J, Dubach UC, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1556-9. PubMed ID: 2221865
    [Abstract] [Full Text] [Related]

  • 13. Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil.
    Holford NH, Ambros RJ, Stoeckel K.
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):421-42. PubMed ID: 1287195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cefetamet pivoxil in community-acquired pneumonia: an overview.
    Kissling M.
    Curr Med Res Opin; 1992 Oct; 12(10):631-9. PubMed ID: 1633721
    [Abstract] [Full Text] [Related]

  • 16. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
    Grassi GG.
    Drugs; 1994 Oct; 47 Suppl 3():35-42. PubMed ID: 7518765
    [Abstract] [Full Text] [Related]

  • 17. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K, Harell M, Dan M.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cefetamet pivoxil in otitis media.
    Quevedo A, Sossouhounto R, Kissling M.
    ORL J Otorhinolaryngol Relat Spec; 1993 Mar; 55(2):93-6. PubMed ID: 8446394
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.